Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | CRHBP | P24387 | 2/20 | 0.48 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22118102 | 1.00 | MAPT (0.53) | MAPTLMNAHTTBLMKDM4E | |
| SCHEMBL15503174 | 1.00 | MAPT (0.53) | MAPTLMNAHTTBLMKDM4E | |
| SCHEMBL15503300 | 1.00 | MAPT (0.53) | MAPTLMNAHTTBLMKDM4E | |
| SCHEMBL30301362 | 1.00 | MAPT (0.53) | MAPTLMNAHTTBLMKDM4E | |
| SCHEMBL14156065 | 1.00 | MAPT (0.53) | MAPTLMNAHTTBLMKDM4E | |
| SCHEMBL30061260 | 1.00 | MAPT (0.53) | MAPTLMNAHTTBLMKDM4E | |
| SCHEMBL12533554 | 1.00 | MAPT (0.53) | MAPTLMNAHTTBLMKDM4E | |
| SCHEMBL408107 | 0.95 | LMNA (0.59) | MAPTLMNAHTTBLMKDM4E | |
| SCHEMBL84835 | 0.94 | TRPV1 (0.49) | MAPTSMN1; SMN2KMT2ATRPV1MEN1 | |
| SCHEMBL14176972 | 0.92 | MAPT (0.46) | MAPTLMNAHTTBLMKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113262637-B | Electromigration separation and enrichment 6 Method for producing Li isotopes | 中国科学院青海盐湖研究所 | 2023-10-17 | — | — | CN | claimed |
| WO-2026102309-A1 | SELECTIVE RADIOTRACERS AND METHODS OF USE | LUTROO IMAGING, LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4547612-A1 | METHOD AND COMPOSITION FOR LIQUID-LIQUID EXTRACTION | Molten Salt Solutions, Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| US-20250135403-A1 | METHOD AND COMPOSITION FOR LIQUID-LIQUID EXTRACTION | MOLTEN SALT SOLUTIONS INC. | 2025-05-01 | — | — | US | disclosed |
| WO-2024006437-A1 | METHOD AND COMPOSITION FOR LIQUID-LIQUID EXTRACTION | Molten Salt Solutions, LLC (US) | 2024-01-04 | — | — | WO | disclosed |
| CN-113262637-B | Electromigration separation and enrichment 6 Method for producing Li isotopes | 中国科学院青海盐湖研究所 | 2023-10-17 | — | — | CN | disclosed |
| US-20220306663-A1 | Metal Tricarbonyl Complexes Comprising Substituted Iminodiactic Acid Ligands and Uses as Radioisotope Tracers | UNIV EMORY (US) | 2022-09-29 | — | — | US | disclosed |
| US-11384106-B2 | Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers | EMORY UNIVERSITY (US) | 2022-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220306663-A1 | Metal Tricarbonyl Complexes Comprising Substituted Iminodiactic Acid Ligands and Uses as Radioisotope Tracers | SLC16A8, S100A8, FGF23 | MAPT 3477/4885LMNA 3675/4885HTT 1603/4885 |
| US-11384106-B2 | Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers | SLC16A8, S100A8, FGF23 | MAPT 3477/4885LMNA 3675/4885HTT 1603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.